We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
81 hedge funds and large institutions have $540M invested in Revance Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
133% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 6
55% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 20
17% more capital invested
Capital invested by funds: $463M → $540M (+$77M)
9% more funds holding
Funds holding: 74 → 81 (+7)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
81
Holders Change
+7
Holders Change %
+9.46%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
14
Increased
31
Reduced
20
Closed
6
Calls
$364K
Puts
–
Net Calls
+$364K
Net Calls Change
+$526K
Top Buyers
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$3.27M |
| 2 |
Franklin Resources
San Mateo,
California
|
+$2.9M |
| 3 |
JP Morgan Chase
New York
|
+$2.72M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.67M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.34M |
